Duragesic Pain Patch

FEBRUARY 14, 2008 ALERT:
Johnson and Johnson has issued a recall on its Duragesic Pain Patch after it was found that a leak of the active ingredient, Fentanyl, could prove potentially fatal to patients or those around them.
Call Brown & Crouppen at Toll-Free: 866-991-4700 for your free legal consultation or save time with our online Contact Form.
Brown & Crouppen has been building a reputation for success for over a quarter of a century. We have thrived because of our shared commitment to deliver the best possible service to clients throughout Missouri and the United States. We share a vision of making a real difference in people’s lives. In the past several years, we have represented many people injured by unsafe drugs and medical devices. Brown & Crouppen attorneys have invested significant effort and resources to ensure that big drug companies are held accountable for the devastating impact their dangerous products have on people’s lives. With the support of some of the nation’s premier drug litigation specialists, we are able to offer our clients legal expertise that is second to none. Some of the more well known prescription drug litigation cases we’ve handled include Rezulin, Fen-Phen, Lotronex, OxyContin, Prempro, Baycol, PPA, and Zyprexa.
Flawed Duragesic Pain Patches Recalled Because Of Potential For
Lethal Overdose
A unit of Johnson & Johnson has announced a voluntary recall of its Duragesic
pain patch over fears that a leak could expose patients or caregivers to a
lethal dose of a potent painkiller.
The recall, announced Feb. 12, is being conducted in cooperation with the U.S.
Food and Drug Administration. News reports indicate that as many as 32 million
of the Duragesic pain patches could be recalled. An estimated two patches out of
every million may leak.
The recall is for the Duragesic 25 microgram-per-hour patches with expiration
dates on or before December 2009. All are manufactured by ALZA Corporation. Also
on the recall list is a generic Sandoz Inc. 25 microgram-per-hour pain patch.
The Duragesic and Sandoz patches contain the painkiller fentanyl. That Schedule
II opioid medication was originally approved in 1990 to treat acute,
postoperative and moderate-to-severe pain. Applied to the skin, the Duragesic
adhesive patch delivers a powerful and constant dose of fentanyl in gel form,
providing pain relief for up to 3 days.
The problem, according to a press release on Johnson & Johnson’s Web site: the
recalled patches may have a cut along one side of the drug reservoir within the
patch, allowing the gel to seep out. The cut edge in affected patches can be
seen upon opening the sealed foil pouch that holds the patch. At least six
defective patches have already turned up.
The leak has the potential to deliver a deadly dose of the drug. Too much
fentanyl gel can lead to “serious adverse events, including respiratory
depression and possible overdose, which may be fatal,” the recall notice said.
The company warned anyone who comes in contact with fentanyl gel to “thoroughly
rinse exposed skin with large amounts of water only; do not use soap.
Immediately dispose of affected patches with cut edges by flushing them down the
toilet, using caution not to handle them directly.”
Patches with a cut edge that have leaked gel will not provide effective pain
relief, the press release said.
Patients with the recalled 25 mcg/hr Duragesic patches were asked to call (800)
547-6446, while patients with the recalled 25 mcg/hr Sandoz Inc. patches were
asked to call (800) 901-7236.
This is not the first time that pain patches have made headlines. Janssen
Pharmaceutica Products, owned by Johnson & Johnson, issued a recall of all of
their 75mcg/hr Duragesic patches in February 2004 due to a potential breach in
the seal on one edge of the patch.
In July 2005, the FDA launched an investigation after 120 deaths were linked to
patches which utilized fentanyl for pain control. And last December, the U.S.
Food and Drug Administration issued a safety warning about the patches, saying
improper use could cause breathing difficulties and death.
You should be alert to the possibility of receiving a defective patch and its
associated risks of overdose or inadequate control of pain. If you or someone
you love believes they have experienced adverse effects resulting from the
Duragesic patch, it is important to contact your doctor for health advice. It is
also in your best interests to consult with a qualified personal injury attorney
who can help protect your legal rights. It is important to act quickly since
there may be a limited timeframe in which to file a claim. When you need
top-notch legal skills and the support of an experienced team of professionals
-- call Brown & Crouppen.
At Brown & Crouppen our experienced team of defective drug lawyers provides
tough, aggressive representation for Duragesic pain patch victims and their
families. When you choose us to handle your lawsuit, our entire team becomes
fully committed to your cause. We’ll find answers, hold negligent companies
responsible and get you the compensation you deserve.
Brown & Crouppen can help you make informed decisions about your
legal rights, so please call Brown & Crouppen at Toll
Free: 866-991-4700 for your free legal consultation or save time with
our online
Contact Form.
Call Brown & Crouppen at
Toll-Free: 866-991-4700 for your free
legal consultation or save time with our online
Contact Form.
Toll-Free: 866-991-4700
